MedTrace Logo

THRIVE: Culturally AdapTed Harm Reduction Intervention

NCT06609278 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2026-05-07

Study results available
· View outcomes & findings →

Summary

The goal of this study is to develop and test a culturally adapted harm reduction intervention among Black adults who misuse opioids and/or stimulants. The questions it aims to answer include: will the culturally adapted harm reduction educational intervention increase overall knowledge of overdose and prevention/intervention techniques and increase confidence and willingness to use/teach interventions to others at-risk.

Conditions

  • Opioid Use
  • Stimulant Use

Interventions

BEHAVIORAL

harm reduction intervention

Each participant will complete a pre-test at Study Visit 1 prior to the intervention, participate in the intervention, then complete a post-test. After the intervention, participants will participate in a recorded focus group. Participants will be offered FTS, Narcan, first aid supplies at the study visit.

Sponsors & Collaborators

  • University of Cincinnati

    collaborator OTHER

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • Brittany Miller-Roenigk

    lead OTHER

Principal Investigators

  • Brittany Miller-Roenigk, PhD · University of Kentucky

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-02
Primary Completion
2025-06-20
Completion
2025-06-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06609278 on ClinicalTrials.gov